Results 191 to 200 of about 1,665,519 (290)

Plant‐Derived Bioactives and PPAR Signaling in Functional Dyspepsia: Mechanistic Insights and Therapeutic Perspectives

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6553-6563, November 2026.
Functional dyspepsia involves duodenal barrier dysfunction, low‐grade immune activation and altered neuroimmune signalling. Various plant‐derived bioactives may modulate PPAR signalling, reduce inflammatory and oxidative stress, and support epithelial, immune, metabolic, and sensory homeostasis.
Irene Palenca   +5 more
wiley   +1 more source

Cannabidiphorol (CBDP) acts as a negative allosteric modulator at two distinct sites of cannabinoid receptor 1. [PDF]

open access: yesCommun Chem
Pandey P   +7 more
europepmc   +1 more source

Dietary Echinacea purpurea Attenuates Oxidative Stress and Alters Cytokine Gene Expression Among Heat‐Stressed Broiler Chickens at High Altitude

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
Dietary Echinacea purpurea (0.75%) alleviated oxidative stress (↓NO, ↓MDA) and selectively upregulated IL‐10 and IFN‐γ expression in heat‐stressed broilers at high altitude, shifting the cytokine balance toward an anti‐inflammatory state without affecting telomere length.
Shahab Bahadoran   +2 more
wiley   +1 more source

Global Prognostic Impact of Substance Use in Alcohol‐Associated Hepatitis

open access: yesAlcohol, Clinical and Experimental Research, Volume 50, Issue 11, November 2026.
Alcohol‐associated hepatitis (AH) carries high short‐term mortality, yet behavioral risk factors are not captured by current prognostic models. In this multinational cohort of 814 patients, active cannabis use independently predicted mortality after accounting for liver disease severity and transplantation as a competing‐risk.
Omar Albhaisi   +49 more
wiley   +1 more source

Targeting mechanosensitive cannabinoid receptor 1 with isoflavone prodrugs attenuates atherosclerotic endothelial dysfunction. [PDF]

open access: yesJ Biomed Sci
Chung DJ   +12 more
europepmc   +1 more source

From emergence to replacement: The evolution of 3‐methylmethcathinone (3‐MMC) and its substitutes in the Dutch drug market (2012–2024)

open access: yesAddiction, Volume 121, Issue 11, Page 3065-3074, November 2026.
Abstract Background and aims The market for new psychoactive substances (NPS) is highly dynamic, with hundreds of substances emerging on the European drug market in the last decade. 3‐methylmethcathinone (3‐MMC), a synthetic cathinone and isomer of mephedrone (4‐MMC), gained popularity in the Netherlands due to its psychostimulant effects and initial ...
Nadia Robert Petronella Wilhelmina Hutten   +4 more
wiley   +1 more source

Opioid withdrawal syndrome‐associated cognitive impairment: A narrative review

open access: yesThe American Journal on Addictions, Volume 35, Issue 6, Page 661-672, November 2026.
Abstract Background and Objectives Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid use and addiction, little is known about cognitive impairment that may specifically accompany OWS.
Faizan Khan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy